Cleared Traditional

K202412 - ClearRT Helical kVCT for the Radixact Treatment Delivery System

K202412 is an FDA 510(k) clearance for ClearRT Helical kVCT for the Radixact T..., manufactured by Accuray Incorporated. The device is a Class 2 Radiology device with product code IYE cleared through the Traditional 510(k) pathway after a 116-day FDA review.

K202412 · Accuray Incorporated · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2020
Decision
116d
Days
Class 2
Risk

K202412 is an FDA 510(k) clearance for the ClearRT Helical kVCT for the Radixact Treatment Delivery System. Classified as Accelerator, Linear, Medical (product code IYE), Class II - Special Controls.

Submitted by Accuray Incorporated (Madison, US). The FDA issued a Cleared decision on December 18, 2020 after a review of 116 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Accuray Incorporated devices

FDA 510(k) Submission Details - K202412

510(k) Number K202412 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 24, 2020
Decision Date December 18, 2020
Days to Decision 116 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
9d slower than avg
Panel avg: 107d · This submission: 116d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

IYE Device Classification - Class 2, Special Controls

Product Code IYE Accelerator, Linear, Medical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IYE Accelerator, Linear, Medical

All 532
Devices cleared under the same product code (IYE) and FDA review panel - the closest regulatory comparables to K202412.
Identify
K210835 · Varian Medical Systems, Inc. · Apr 2021
AlignRT Plus
K203387 · Vision Rt, Ltd. · Mar 2021
Mobius3D
K203669 · Varian Medical Systems, Inc. · Jan 2021
MOSAIQ Oncology Information System
K203172 · Elekta Solutions AB · Dec 2020
BeamSite
K200940 · Doseoptics, LLC · Dec 2020
ExacTrac Dynamic
K203173 · Brainlab AG · Nov 2020